Furthermore, loss-of-function mutations in KCC2 are causally linked with human infantile epilepsy and KCC2 impairment have been found in patients with idiopathic and acquired epilepsy (Moore et al., 2017). This evidence concerns the gene SLC12A5 and infantile epilepsy syndrome.